Survival-based CRISPR genetic screens across a panel of permissive cell lines identify common and cell-specific

Katherine Chan1, Adrian Granda Farias1,2, Hunsang Lee1

  • 1Donnelly Center, 160 College Street, University of Toronto, Toronto, Ontario, Canada, M5S3E1.

Heliyon
|January 4, 2023
PubMed

Insights

Researchers identified host cell factors crucial for SARS-CoV-2 infection using CRISPR screens. Only ACE2 was a common factor across all cell types, highlighting cell-specific dependencies for potential antiviral therapies.

Area of Science:

  • Virology
  • Genetics
  • Cell Biology

Background:

  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) relies on host cell machinery for its life cycle.
  • Understanding virus-host interactions is key to developing antiviral strategies.
  • Host dependency factors, if targetable, offer potential therapeutic avenues.

Purpose of the Study:

  • To identify host genetic factors regulating SARS-CoV-2 infection across various cell types.
  • To explore potential antiviral targets by pinpointing essential host dependencies.

Main Methods:

  • Genome-wide CRISPR knockout screens were conducted in multiple cell lines (Vero E6, Calu-3, UM-UC-4, HEK-293, HuH-7).
  • Analysis focused on identifying genes essential for SARS-CoV-2 replication and infection.

Main Results:

  • Angiotensin-converting enzyme 2 (ACE2) was the sole common host dependency factor identified across all tested cell lines.
  • Other identified host factors, including TMPRSS2 and CTSL, were largely cell line-specific.
  • Convergent pathways implicated included cell signaling, immune responses, and chromatin modification.
  • Perturbation of the chromatin modifier KMT2C in Calu-3 cells showed the most significant impact on inhibiting SARS-CoV-2 infection.

Conclusions:

  • Host dependency for SARS-CoV-2 infection is predominantly cell-type specific, with ACE2 being a universal factor.
  • The study reveals novel host factors and pathways involved in viral infection, offering potential targets for antiviral drug development.
  • Targeting specific host factors like KMT2C could represent a promising strategy for therapeutic intervention against SARS-CoV-2.